Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ChronoScale Holdings CorpCHRN · Entity 4331 | Director · Chief Executive Officer | July 13, 2026 | July 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ChronoScale Holdings Corp
Report date July 13, 2026 · Filed July 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,800,000 |
Reported balance
After 2026-07-13 transaction · row 1
1 source rowRow 1 · 2026-07-13 · Grant · Acquired 2,800,000 · Balance 2,800,000 F1: Restricted stock units ("RSUs") granted on July 13, 2026 (the "Grant Date") represent a contingent right to receive shares of common stock of ChronoScale Holdings Corporation (the "Issuer") on a one-for-one basis, have no expiration date, and vest as follows: one-third of the RSUs will vest on May 1, 2027 (the "Cliff Date"), with one-sixth of the remaining RSUs vesting in equal installments every six months after the Cliff Date, such that the RSUs will be fully vested on May 1, 2029, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date and subject to accelerated vesting upon certain conditions. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units ("RSUs") granted on July 13, 2026 (the "Grant Date") represent a contingent right to receive shares of common stock of ChronoScale Holdings Corporation (the "Issuer") on a one-for-one basis, have no expiration date, and vest as follows: one-third of the RSUs will vest on May 1, 2027 (the "Cliff Date"), with one-sixth of the remaining RSUs vesting in equal installments every six months after the Cliff Date, such that the RSUs will be fully vested on May 1, 2029, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date and subject to accelerated vesting upon certain conditions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 13, 2026 Filed Jul 15, 2026 20:15 UTC | ChronoScale Holdings Corp CHRN · Entity 4331 | GrantCommon Stock | 2,800,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-033359 · ownership.xml · nonDerivative · entry 1 Chen Ying Cenly · CIK 0002132614 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,800,000 F1 · shares: Restricted stock units ("RSUs") granted on July 13, 2026 (the "Grant Date") represent a contingent right to receive shares of common stock of ChronoScale Holdings Corporation (the "Issuer") on a one-for-one basis, have no expiration date, and vest as follows: one-third of the RSUs will vest on May 1, 2027 (the "Cliff Date"), with one-sixth of the remaining RSUs vesting in equal installments every six months after the Cliff Date, such that the RSUs will be fully vested on May 1, 2029, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date and subject to accelerated vesting upon certain conditions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.